You must log in to view this page.

Cadrenal Therapeutics Inc. – Filings and Transcripts

NASDAQ: CVKD
Share price (10/21/26): $1.02
Market cap (10/21/26): $3.639 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Exempt offering of securities

Shelf registration

Ownership Filter

Golden Lee Scott

Murphy John Raymond

Cole Jeffrey Scott

News Filter

Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of Its Orphan Thrombo-Inflammatory Therapeutics

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Announces Positive Outcome From FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process

Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC